{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:37:11Z","timestamp":1789983431036,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.diabres.2022.110093","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T02:06:52Z","timestamp":1664849212000},"page":"110093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Characteristics and outcomes of patients with type 1 diabetes admitted with acute coronary syndromes"],"prefix":"10.1016","volume":"192","author":[{"given":"Marcel M.","family":"Nejatian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick S.R.","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bu B.","family":"Yeap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Gerry","family":"Fegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul R.","family":"Ihdayhid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10146","key":"10.1016\/j.diabres.2022.110093_b0005","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study","volume":"392","author":"Rawshani","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.diabres.2022.110093_b0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S2213-8587(14)70248-7","article-title":"Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis","volume":"3","author":"Huxley","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.diabres.2022.110093_b0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/2040622315598502","article-title":"Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population","volume":"6","author":"Lee","year":"2015","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.diabres.2022.110093_b0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijcard.2016.04.182","article-title":"A systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction","volume":"217","author":"Bauters","year":"2016","journal-title":"Int J Cardiol"},{"issue":"16","key":"10.1016\/j.diabres.2022.110093_b0025","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.116.025961","article-title":"Range of Risk Factor Levels: Control, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes Mellitus","volume":"135","author":"Rawshani","year":"2017","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.diabres.2022.110093_b0030","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1161\/CIRCULATIONAHA.118.037454","article-title":"Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus","volume":"139","author":"Rawshani","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.diabres.2022.110093_b0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jdiacomp.2019.01.006","article-title":"Undiagnosed coronary artery disease in long-term type 1 diabetes The Dialong study","volume":"33","author":"Holte","year":"2019","journal-title":"J Diabetes Complications"},{"issue":"5","key":"10.1016\/j.diabres.2022.110093_b0040","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/dc15-1990","article-title":"Complications Trial \/Epidemiology of Diabetes I, Complications Study Research G. Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT\/EDIC Study 30-Year Follow-up","volume":"39","author":"Diabetes","year":"2016","journal-title":"Diabetes Care"},{"issue":"9607","key":"10.1016\/j.diabres.2022.110093_b0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Cholesterol Treatment Trialists","year":"2008","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.diabres.2022.110093_b0050","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.amjcard.2014.07.031","article-title":"Impact of diabetes mellitus on clinical characteristics, management, and in-hospital outcomes in patients with acute myocardial infarction (from the NCDR)","volume":"114","author":"Rousan","year":"2014","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.diabres.2022.110093_b0055","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.298.7.765","article-title":"Diabetes and mortality following acute coronary syndromes","volume":"298","author":"Donahoe","year":"2007","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.diabres.2022.110093_b0060","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archinte.164.13.1457","article-title":"Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events","volume":"164","author":"Franklin","year":"2004","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.diabres.2022.110093_b0065","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2337\/diacare.26.5.1427","article-title":"Processes and outcomes of care for diabetic acute myocardial infarction patients in Ontario: do physicians undertreat?","volume":"26","author":"Alter","year":"2003","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.diabres.2022.110093_b0070","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1161\/01.CIR.0000142047.28024.F2","article-title":"Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial","volume":"110","author":"Aguilar","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.diabres.2022.110093_b0075","doi-asserted-by":"crossref","first-page":"518","DOI":"10.5694\/mja2.51336","article-title":"Revision of the Australian guidelines to reduce health risks from drinking alcohol","volume":"215","author":"Conigrave","year":"2021","journal-title":"Med J Aust"},{"key":"10.1016\/j.diabres.2022.110093_b0080","doi-asserted-by":"crossref","unstructured":"Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;42(34): 3227\u20133337.","DOI":"10.1093\/eurheartj\/ehab484"},{"issue":"24","key":"10.1016\/j.diabres.2022.110093_b0085","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.diabres.2022.110093_b0090","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth Universal Definition of Myocardial Infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2022.110093_b0095","doi-asserted-by":"crossref","unstructured":"Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2): 255\u2013323.","DOI":"10.1093\/eurheartj\/ehz486"},{"issue":"12","key":"10.1016\/j.diabres.2022.110093_b0100","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1111\/dom.13848","article-title":"Double diabetes: A distinct high-risk group?","volume":"21","author":"Kietsiriroje","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.diabres.2022.110093_b0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5152\/eurasianjmed.2022.21039","article-title":"Prevalence of Insulin Resistance in Type 1 Diabetes Mellitus and Its Correlation with Metabolic Parameters: The Double Trouble","volume":"54","author":"Pathak","year":"2022","journal-title":"Eurasian J Med"},{"issue":"4","key":"10.1016\/j.diabres.2022.110093_b0110","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2337\/diabetes.49.4.626","article-title":"Can clinical factors estimate insulin resistance in type 1 diabetes?","volume":"49","author":"Williams","year":"2000","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.diabres.2022.110093_b0115","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/dc17-1732","article-title":"Prognostic Value of the Acute-to-Chronic Glycemic Ratio at Admission in Acute Myocardial Infarction: A Prospective Study","volume":"41","author":"Marenzi","year":"2018","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.diabres.2022.110093_b0120","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"issue":"1","key":"10.1016\/j.diabres.2022.110093_b0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","article-title":"Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review","volume":"21","author":"Bosco","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.diabres.2022.110093_b0130","doi-asserted-by":"crossref","unstructured":"Haberka M, Jankowski P, Kosior DA, et al. Treatment goal attainment for secondary prevention in coronary patients with or without diabetes mellitus: Polish multicenter study POLASPIRE. Archives of Medical Science. 2021.","DOI":"10.5114\/aoms.2020.92558"},{"issue":"8","key":"10.1016\/j.diabres.2022.110093_b0135","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/dc12-2258","article-title":"The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988\u20132010","volume":"36","author":"Stark Casagrande","year":"2013","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2022.110093_b0140","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/db15-1517","article-title":"Complications Trial\/Epidemiology of Diabetes I, Complications Research G. Risk Factors for Cardiovascular Disease in Type 1 Diabetes","volume":"65","author":"Diabetes","year":"2016","journal-title":"Diabetes"},{"issue":"21","key":"10.1016\/j.diabres.2022.110093_b0145","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","article-title":"Glycemic control and excess mortality in type 1 diabetes","volume":"371","author":"Lind","year":"2014","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.diabres.2022.110093_b0150","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.2337\/diabetes.52.11.2833","article-title":"Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study","volume":"52","author":"Dabelea","year":"2003","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.diabres.2022.110093_b0155","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1089\/dia.2011.0046","article-title":"Obesity and coronary artery calcium in diabetes: the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study","volume":"13","author":"Rodrigues","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2022.110093_b0160","doi-asserted-by":"crossref","unstructured":"Lan NSR, Fegan PG, Yeap BB, Bell DA, Watts GF. Dyslipidaemia in adults with type 1 diabetes-when to treat? Diabetes Metab Res Rev. 2019;35(1): e3090.","DOI":"10.1002\/dmrr.3090"},{"issue":"10","key":"10.1016\/j.diabres.2022.110093_b0165","doi-asserted-by":"crossref","first-page":"e007682","DOI":"10.1161\/CIRCOUTCOMES.120.007682","article-title":"Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes","volume":"14","author":"Thomas","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"10.1016\/j.diabres.2022.110093_b0170","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/dom.13110","article-title":"Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes","volume":"20","author":"Nystrom","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"16","key":"10.1016\/j.diabres.2022.110093_b0175","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/heartjnl-2015-307627","article-title":"Improving 30-day case fatality after incident myocardial infarction in people with diabetes between 1998 and 2010","volume":"101","author":"Nedkoff","year":"2015","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.diabres.2022.110093_b0180","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1161\/CIRCULATIONAHA.107.740498","article-title":"Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk","volume":"117","author":"Kosiborod","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.diabres.2022.110093_b0185","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2337\/dc18-2047","article-title":"Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome","volume":"42","author":"Gerbaud","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2022.110093_b0190","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jacc.2005.03.052","article-title":"U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction","volume":"46","author":"Pinto","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.diabres.2022.110093_b0195","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/eurheartj\/ehi230","article-title":"Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events","volume":"26","author":"Svensson","year":"2005","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.diabres.2022.110093_b0200","first-page":"263","article-title":"Predictors of adverse outcome in a diabetic population following acute coronary syndromes","volume":"30","author":"Lourenco","year":"2011","journal-title":"Rev Port Cardiol"},{"issue":"3","key":"10.1016\/j.diabres.2022.110093_b0205","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0735-1097(93)90180-9","article-title":"Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator\/Streptokinase Mortality Trial","volume":"22","author":"Barbash","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.diabres.2022.110093_b0210","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.2337\/dc11-s209","article-title":"Heart in diabetes: a microvascular disease","volume":"34","author":"Laakso","year":"2011","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2022.110093_b0215","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94121-8","article-title":"Cardiovascular risk factors associated with acute myocardial infarction and stroke in the MADIABETES cohort","volume":"11","author":"Salinero-Fort","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.diabres.2022.110093_b0220","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S2213-8587(16)30057-2","article-title":"Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study","volume":"4","author":"Brownrigg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.diabres.2022.110093_b0225","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2337\/diacare.27.2.530","article-title":"Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study","volume":"27","author":"Soedamah-Muthu","year":"2004","journal-title":"Diabetes Care"},{"issue":"23","key":"10.1016\/j.diabres.2022.110093_b0230","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1136\/heartjnl-2014-305657","article-title":"Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus","volume":"100","author":"Brownrigg","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.diabres.2022.110093_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/2161085","article-title":"Micro- and Macrovascular Complications in Diabetes Mellitus: Preclinical and Clinical Studies","volume":"2019","author":"Rangel","year":"2019","journal-title":"J Diabetes Res"},{"issue":"9","key":"10.1016\/j.diabres.2022.110093_b0240","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.2337\/dc19-0480","article-title":"Optimal Blood Pressure Thresholds for Minimal Coronary Artery Disease Risk in Type 1 Diabetes","volume":"42","author":"Guo","year":"2019","journal-title":"Diabetes Care"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272200907X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272200907X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:22:52Z","timestamp":1759173772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882272200907X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":48,"alternative-id":["S016882272200907X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110093","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and outcomes of patients with type 1 diabetes admitted with acute coronary syndromes","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110093"}}